<DOC>
	<DOC>NCT01264107</DOC>
	<brief_summary>An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine.</brief_summary>
	<brief_title>An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis, Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B, Chronic</mesh_term>
	<mesh_term>Clevudine</mesh_term>
	<criteria>1. Patients is currently clevudine treatment. 2. Patients with HBV DNA ï¼œ 300 cpoies/mL and ALT normal Showing Musclerelated Symptom Who received Clevudine 3. Patient who is able to give written informed consent prior to study start and to comply with the study requirements. 1. Patient is currently receiving antiviral, immunomodulatory, cytotoxic or corticosteroid therapy. 2. Patient is pregnant or breastfeeding. 3. Patient has a significant gastrointestinal, renal, decompensated liver, bronchopulmonary, neurological, cardiac, oncologic(except HCC)or allergic disease. 4. Patient, in the opinion of the investigator, unsuitable for the study. 5. Showing Musclerelated Symptom who any other evidence.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>